Next Generation Dx Summit 2014 – Speaker List – Speaker Biographies
Gyorgy Abel, M.D., Ph.D., Director, Molecular Diagnostics, Immunology & Clinical Chemistry, Laboratory Medicine, Lahey Hospital & Medical Center
Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
Chong H. Ahn, Ph.D., Mitchell P. Kartalia Chair and Professor, Microsystems and BioMEMS Laboratory, School of Electronics and Computing Systems, University of Cincinnati
Randy Allen, Ph.D., Director, Global Markets Team, Clinton Health Access Initiative (CHAI)
Sami S. Amr, Ph.D., Instructor, Pathology, Harvard Medical School; Director, PCPGM Research Core; Assistant Director, Lab for Molecular Medicine, Partners Center for Personalized Genetic Medicine
Philipp Angenendt, Ph.D., Director, Global Operations, Sysmex Inostics GmbH
Mike Barlow, Vice President, Palmetto GBA
J. Carl Barrett, Ph.D., Vice President, Translational Sciences, Onc iMed, AstraZeneca
Lora J.H. Bean, Ph.D., F.A.C.M.G., Assistant Professor, Senior Director, Molecular Diagnostic Laboratory, Emory Genetics Laboratory, Human Genetics, Emory University
Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbH
Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurological Surgery, Johns Hopkins University School of Medicine
Mark S. Boguski, M.D., Ph.D., Associate Professor, Pathology, Center for Biomedical Informatics, Harvard Medical School
Robert A. Bonomo, M.D., Chief, Medical Service, Louis Stokes Cleveland VA Hospital; Vice Chair, Veterans Affair, Medicine, University Hospital Case Medical Center
Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young, M.D., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center
Roslyn Brandon, Ph.D., CEO and Co-Founder, Immunexpress
Catherine Brownstein, M.D., Instructor, Pediatrics, Harvard Medical School and Boston Children’s Hospital
Tracy Bush, Ph.D., Director and Global Coordinator, Companion Diagnostics, Regulatory Affairs, Roche Diagnostics
Lon Castle, M.D., Medical Science Liaison, Medical Affairs, CardioDx
Rong Chen, Ph.D., Assistant Professor, Genetics and Genomic Sciences; Director, Clinical Genome Informatics, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Charles Chiu, M.D., Ph.D., Assistant Professor, Lab Medicine and Medicine, Infectious Diseases, University of California San Francisco Melina Cimler, Ph.D., Vice President, Head, Global Quality, Illumina, Inc.
John Clarkson, Chief Executive, Atlas Genetics Ltd.
Barbara Conley, M.D., Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Laura Conlin, Ph.D., FACMG, Scientific Director, Division of Genomic Diagnostics, Children’s Hospital of Philadelphia; Assistant Professor, Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania
Robert Cook-Deegan, M.D., Research Professor, Institute for Genome Sciences & Policy, Sanford School of Public Policy, Duke University
Seth D. Crosby, M.D., Director, Alliances and Partnerships, Genetics, Washington University School of Medicine
Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations, Bio-Reference Laboratories
Shahriar Dadkhah, M.D., MBA, FACC, FSCAI, Associate Professor, Medicine, University of Illinois; Director, Cardiology Research, Saint Francis Hospital
Baabi Das, MBA, President and Founder, Zansors
Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Jennifer Dickey, RAC, Ph.D., Office of In Vitro Diagnostics, DIHD, US Food and Drug Administration
David P. Dimmock, M.D., Associate Professor, Pediatrics, Medical College of Wisconsin
Kenneth Emancipator, M.D., Director, Companion Diagnostics, Merck Research Laboratories
Mark T. Esser, Ph.D., Director, Translational Medicine, Infectious Diseases and Vaccines, MedImmune
David Erickson, Ph.D., Associate Professor, Sibley School of Mechanical & Aerospace Engineering, Cornell University
Brigitte Faas, Ph.D., Clinical Cytogeneticist, Human Genetics, Radboud University Nijmegen Medical Center
Helen Fernandes, Ph.D., Pathology & Laboratory Medicine, Weill Cornell Medical College
Carlos Gil Ferreira, M.D., Executive Director, INOVA-CANCER; Director, Clinical Research, Brazilian National Cancer Institute
Thomas M. File, Jr. M.D., MSc, MACP, FIDSA, FCCP, Chair, Infectious Disease Division, Summa Health System; Professor, Internal Medicine; Master Teacher; Chair, Infectious Disease Section, Northeast Ohio Medical University (NEOMED)
Andrew C. Fish, Executive Director, AdvaMedDx
Eric Fung, M.D., Ph.D., Vice President, Research and Development, Clinical Applications, Affymetrix
David W. Gee, Partner, Davis Wright Tremaine LLP
Jeremy Goecks, Ph.D., Assistant Professor, Computational Biology, Integrative Systems Biology and The Computational Biology Institute, George Washington University
Wayne W. Grody, M.D., Ph.D., Professor, Medical Genetics and Molecular Pathology, Pathology & Lab Medicine, Pediatrics, and Human Genetics; Director, Molecular Diagnostic Laboratories and Clinical Genomics Center, UCLA School of Medicine
John W. Hanna, Senior Director, Policy & Reimbursement, Veracyte
Kevin M. Harter, President and CEO, Saladax Biomedical
Matthew J. Hawryluk, Ph.D., Senior Director, Corporate & Business Development, Foundation Medicine, Inc.
Madhuri Hegde, Ph.D., FACMG, Associate Professor, Human Genetics; Executive Director, Emory Genetics Laboratory, Emory University School of Medicine
Michael J. Heller, Ph.D., Professor, Nanoengineering & Bioengineering, University of California San Diego
James Hicks, Ph.D., Research Professor, Cancer Genomics, Cold Spring Harbor Laboratory
Mark Hills, Ph.D., Research Scientist, Peter M. Lansdorp Laboratory, BC Cancer Research Centre
David Himsworth, Director, Clinical Affairs, Luminex Corporation
Dave S. B. Hoon, MSc, Ph.D., CSI & Director, Molecular Oncology; Director, JWCI Sequencing Center, John Wayne Cancer Institute
Patric Hooper, Founding Partner, Hooper, Lundy & Bookman, PC
Joany Jackman, Ph.D., Investigator, Center for Point of Care Tests for STD, Johns Hopkins University School of Medicine
Pawan K. Jain, M.D., Ph.D., Senior Regulatory Scientist, Division of Emerging and Transfusion Transmitted Disease, Office of Blood Research and Review, Center for Biologics Evaluation Research, FDA
David James, Senior Vice President, IVD Division, Invetech
François Jean, Ph.D., Scientific Director, UBC Facility for Infectious Disease and Epidemic, Research (FINDER); Associate Professor, Microbiology and Immunology, Laboratory for Antimicrobial Therapy, University of British Columbia
Andreas Jeromin, Scientific and Medical Advisor, Quanterix Corporation
Shana Kelley, Ph.D., Chief Technology Officer, Xagenic Inc.
Richard Kellner, CEO, Genome Health Solutions, Inc.
Muin J. Khoury, M.D., Ph.D., NCI Epidemiology and Genomics Research Program, CDC Office of Public Health Genomics
Scott Kopetz, M.D., Ph.D., Associate Professor, Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center
Bruce Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair, Medical Genetics; Professor and Chair,Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham Matthew Kreifels, Manager, Molecular Technology, Streck, Inc.
Parveen Kumar, Research Scientist, Thierry Voet Laboratory, Human Genetics, University of Leuven
Eric Lai, Ph.D., Senior Vice President & Head, Pharmacogenomics, Takeda Pharmaceuticals
Melissa J. Landrum, Ph.D., Staff Scientist, NIH/NLM/NCBI
Nathan A. Ledeboer, Ph.D., D(ABMM), Assistant Professor & Medical Director, Clinical Microbiology, Medical College of Wisconsin
Nicholas J. Lench, Ph.D., FRCPath, Director, NE Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust
Jorge A. Leon, Ph.D., President & CEO, Leomics Associates, Inc.
Zhenyu Li, Ph.D., Assistant Professor, School of Engineering and Applied Science, George Washington University
Matthew Lorence, Ph.D., MBA, TessArae, LLC
Rajyalakshmi Luthra, Ph.D., Director, Molecular Diagnostic Laboratory (MDL) and Molecular Genetic Pathology Fellowship Program; Medical Advisor, Molecular Genetic Technology Program, School of Health Professions; Professor, Hematopathology, The University of Texas MD Anderson Cancer Center
Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP
Sabah Malek, Associate Director, Global Regulatory Affairs, Eisai, Inc.
Jomol Mathew, Ph.D., Director, Clinical and Translational Informatics, IS, Dana-Farber Cancer Institute
Michael Masterman-Smith, Ph.D., Entrepreneurial Scientist, UCLA California NanoSystems Institute
Thomas May, Ph.D., Associate Professor, Bioethics and Medical Humanities; Director, Graduate Program in Bioethics, Center for Bioethics and Medical Humanities, Medical College of Wisconsin
Raja Mazumder, Ph.D., Associate Professor, Biochemistry and Molecular Biology, George Washington University
Daniel McClernon, President, CSO, Virology, bioMONTR Labs
Heather McLaughlin, Ph.D., MB(ASCP)CM, Instructor of Pathology, Massachusetts General Hospital and Harvard Medical School and Assistant Laboratory Director, Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine
Christine Micheel, Ph.D., Research Assistant Professor, Medicine, Vanderbilt-Ingram Cancer Center; Managing Editor, MyCancerGenome.org
Glenn A. Miller, Ph.D., CTO & Executive Vice President, Molecular MD
Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory; Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania Perelman School of Medicine
Muhammed Murtaza, MBBS, Research Assistant Professor and Co-Leader, Program in Circulating Nucleic Acids, TGen, Translational Genomics Research Institute
Jerod Nagel, Pharm.D., BCPS (AQID), Clinical Specialist, Infectious Diseases, Clinical Assistant Instructor, Director Infectious Diseases Residency, University of Michigan Hospital and Health Systems, University of Michigan, College of Pharmacy
Peter Nagy, Ph.D., Director, Clinical Next-Generation Sequencing Lab; Assistant Professor, Pathology and Cell Biology, Columbia University
Peter Nemes, Ph.D., Assistant Professor, Chemistry, George Washington University
Susan M. Novak-Weekley, Ph.D., D(ABMM), Director, Microbiology, Kaiser Permanente, SCPMG Regional Reference Laboratories
Frank S. Ong, M.D., Associate Director, Medical Affairs, Illumina, Inc.
Aydogan Ozcan, Ph.D., Chancellor’s Professor, Electrical Engineering and Bioengineering, University of California Los Angeles; Associate Director, California NanoSystems Institute (CNSI)
David Parker, Ph.D., Vice President, Market Access Strategy, Precision for Medicine
Donald “Will” Parsons, M.D., Ph.D., Assistant Professor, Pediatrics, Molecular & Human Genetics, Baylor College of Medicine, Texas Children’s Cancer Center
Robin Patel, M.D.(CM), FRCP(C), D(ABMM), FIDSA, FACP, F(AAM), Chair, Clinical Microbiology; Consultant, Clinical Microbiology and Infectious Diseases; Professor, Microbiology and Medicine, College of Medicine, Mayo Clinic
Donna Polizio, Associate Director, Government Accounts, Genomic Health
Jason C. Poole, Ph.D., Director, R&D, Trovagene, Inc.
Kristin Ciriello Pothier, Partner/Principal, Ernst and Young
Nick Poulios, Ph.D., Head, MORE, Medical Outcomes: Reimbursement & Economics, Roche Molecular Systems, Inc.
Aniruddha Puntambekar, Ph.D., Executive Vice President, Siloam Biosciences, Inc.
John Quackenbush, Ph.D., Co-Founder and CEO, GenoSpace; Professor, Dana-Farber Cancer Institute and Harvard School of Public Health, Biostatistics and Computational Biology
Erica Ramos, MS, CGC, Clinical Genomics Specialist, Certified Genetic Counselor, New and Emerging Opportunities, Illumina, Inc.
Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology
David A. Rasko, Ph.D., Associate Professor, Microbiology & Immunology, University of Maryland School of Medicine Institute for Genome Sciences
Vincent Ricchiuti, Ph.D., Associate Professor, Director, Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, UC Health University Hospital
Greg Richard, Senior Vice President & General Manager, Interpace Diagnostics, PDI, Inc.
Katherine Richardson, Vice President, R&D, Transgenomic
Marc Salit, Ph.D., Genome-Scale Measurements Group Leader, National Institute of Standards and Technology
Carol Saunders, Ph.D., FACMG, Director, Molecular Genetics Laboratory, Department of Pathology & Laboratory Medicine; Associate Professor, Department of Pathology, UMKC School of Medicine, Children’s Mercy Hospital
Mark Sausen, Ph.D., Director, R&D, Personal Genome Diagnostics
Heinz Schimmel, Ph.D., Scientific Officer, Standards for Innovation and Sustainable Development (SID), European Commission - Joint Research Centre (JRC)
Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen Corporation
Vahan Simonyan, Ph.D., HIVE Project Lead, CBER, FDA
Denis Smirnov, Associate Scientific Director, US Biomarker Oncology, Janssen R&D US
Judi Smith, Vice President, In Vitro Diagnostics and Quality, Precision for Medicine
Matthew Snyder, Graduate Student, Genomic Sciences, University of Washington
Richard St. Clair, Vice President, Commercialization, Evogen Inc.
Gregory Storch, M.D., Ruth L. Siteman Professor of Pediatrics, Director, Divisions of Pediatric Infectious Diseases and Pediatric Laboratory Medicine, Washington University School of Medicine; Medical Director of Clinical Laboratories, St. Louis Children’s Hospital
Michael Super, Ph.D., Senior Staff Scientist, Advanced Technology Team, Wyss Institute at Harvard
W. Fraser Symmans, M.D., Professor & Director, Research Operations, Department of Pathology, UT MD Anderson Cancer Center
AmirAli Talasaz, Ph.D., President & CTO, Guardant Health, Inc.
Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA
Alain R. Thierry, Ph.D., Senior Investigator, Research Institute in Oncology of Montpellier, INSERM
Ali Tinazli, Ph.D., Director & Head, Business Development & Sales, Sony DADC BioSciences, Sony DADC
Peter J. Tonellato, Ph.D., Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School
Ephraim L. Tsalik, M.D., MHS, Ph.D., Assistant Professor, Medicine, Division of Infectious Diseases, Institute for Genome Sciences & Policy, Duke University Medical Center
Sean R. Tunis, M.D., MSc, Founder & Director, Center for Medical Technology Policy
Eric van Gieson, Ph.D., R&D Director, Diagnostics and Biosurveillance, MRIGlobal
Victor E. Velculescu, M.D., Ph.D., Professor, Oncology; Co-Director, Cancer Biology, Johns Hopkins Kimmel Cancer Center
Vickie L. Venne, MS, LGC, Senior Genetic Counselor, Genomic Medicine Service, Department of Veterans Affairs, VA Salt Lake City Health Care System
Jan Vijg, Ph.D., Professor and Chairman, Genetics, Albert Einstein College of Medicine
Gene Walther, MBA, Deputy Director Diagnostics, Global Health, Bill & Melinda Gates Foundation
Yong Wang, Ph.D., Research Scientist, Nicholas E. Navin Laboratory, Genetics, Bioinformatics, MD Anderson Cancer Center
Anton Wellstein, M.D., Ph.D., Professor, Oncology, Pharmacology and Medicine, Georgetown University Medical School; Associate Director, Basic Science, Lombardi Comprehensive Cancer Center
Aaron Wheeler, Ph.D., Director, Wheeler Microfluidics Lab, University of Toronto
Ian White, Ph.D., Assistant Professor, Fischell Department of Bioengineering, University of Maryland
Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.
George M. Whitesides, Ph.D., Woodford L. & Ann A. Flowers Professor, Chemistry & Chemical Biology, Harvard University
P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research
Rina Wolf, Vice President, Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc.
Sunney Xie, Ph.D., Mallinckrodt Professor, Chemistry and Chemical Biology, Harvard University
Roman Yelensky, Ph.D., Senior Director, Biomarker and Companion Diagnostics Development, Foundation Medicine, Inc.
Benjamin Yellen, Ph.D., Associate Professor, Mechanical Engineering and Materials Science, Duke University
Asad R. Zaidi, President & CEO, Epinex Diagnostics, Inc.
Theresa Zhang, Ph.D., Vice President, Research Services, Personal Genome Diagnostics
John F. Zhong, Ph.D., Associate Professor, Pathology, University of Southern California School of Medicine
Justin Zook, Ph.D., Biomedical Engineer, National Institute of Standards and Technology